Riskpilot← Back to searchSign inGet full accessCLINICURO ApS
APSActiveCVR 33590083Dækstensvangen 10Manufacture of pharmaceutical preparations · NACE 2120Est. 20111 employees
Revenue 2025
DKK 201K
-44% vs 2024
EBITDA margin
-145.2%
-114% vs 2024
Equity ratio
-57.2%
Financial strength
Net profit 2025
DKK -524K
-103% vs 2024
| Revenue | DKK 201K | -44% |
| EBITDA | DKK -292K | -114% |
| Net profit | DKK -524K | -103% |
| Total assets | DKK 2,4M | +262% |
| Equity | DKK -1,4M | -63% |
| Employees | 1 | — |
Legal name
CLINICURO ApS
CVR number
33590083
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
31. marts 2011
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive handelsvirksomhed med lægemidler og medicinsk udstyr og dermed beslægtet virksomhed.
Address
Dækstensvangen 10
Phone
+4528149849
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -64 | 243 | 403 | 12 | 283 | 217 | 156 | 428 | 268 | 90 | -27 | 333 | 356 | 201 |
| Staff expenses | -170 | -198 | -174 | -186 | -191 | -188 | -306 | -199 | -151 | -202 | -191 | -495 | -492 | -492 |
| EBITDA | -234 | 45 | 116 | -174 | 92 | 28 | -150 | 228 | 117 | -112 | -218 | -162 | -136 | -292 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -234 | 45 | 116 | -174 | 92 | 28 | -150 | 228 | 117 | -112 | -218 | -162 | -136 | -292 |
| Net financials | -2 | -11 | -12 | 36 | -158 | -22 | -286 | -13 | -20 | -18 | -28 | 274 | -123 | -232 |
| Profit before tax | -235 | 34 | 105 | -223 | -66 | 6 | -303 | 195 | 98 | -130 | -245 | 112 | -259 | -524 |
| Tax | -58 | 8 | 28 | -46 | -21 | -3 | -36 | 44 | 20 | 64 | -0 | -0 | -0 | -0 |
| Net profit | -177 | 25 | 77 | -177 | -45 | 9 | -266 | 151 | 77 | -194 | -245 | 112 | -259 | -524 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 109 | 455 | 412 | 406 | 431 | 341 | 188 | 293 | 257 | 728 | 708 | 638 | 653 | 2.368 |
| Equity | -97 | -72 | 6 | -172 | -217 | -208 | -474 | -323 | -246 | 79 | -167 | -573 | -831 | -1.355 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 206 | 526 | 406 | 578 | 648 | 548 | 662 | 616 | 503 | 649 | 874 | 1.211 | 1.485 | 3.723 |
| Total debt | 206 | 526 | 406 | 578 | 648 | 548 | 662 | 616 | 503 | 649 | 874 | 1.211 | 1.485 | 3.723 |
EBITDA margin
-145.2%
This company
15.8%
Market median
-1019% vs market
20122025
Equity ratio
-57.2%
This company
38.2%
Market median
-250% vs market
20122025
Return on equity
-52389800.0%
This company
18.4%
Market median
-284727274% vs market
20122025
Net profit margin
-260.8%
This company
8.1%
Market median
-3320% vs market
20122025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20122025
Debt / equity
2.75×
This company
0.62×
Market median
-344% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-03-31 – 2012-06-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CLINICURO ApS 
REPOCEUTICALS A/SBoard members of CLINICURO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|